Summary
Cutaneous manifestations of Sjogren’s syndrome (SS) include:
-
• Dry skin (xerosis)
-
• Vasospastic disorders ranging from Raynaud’s to acrocyanosis
-
• Macular, papular and vesicular rashes
-
• Infections such as varicella zoster
-
• Palpable and non-palpable purpura due vasculitis, and
-
• Embolic lesions and thrombotic lesions
-
• Acute or chronic thrombosis with lymphedema
-
• Other associated skin conditions including urticaria or allergic skin eruptions
Complaints of dry skin occur in about 50% of SS patients. It is unclear whether or not the xerosis is due to infiltrate of the eccrine or sebaceous glands, or dysfunctional response of the residual glands. In many biopsies from SS patients, dryness of the skin has been associated with lymphocytic infiltrates in the eccrine glands. Similar to SLE patients, antibody and complement fixation is often detected clinically “normal” skin.
However, the extent of dryness of the skin and the clinical appearance termed “xerosis” is often more severe than that expected for the degree of lymphocytic infiltration (and glandular destruction).
A common finding on deeper skin biopsy is “non-specific perivascular lymphocytic infiltrates.” Immuno-histologic studies have also indicated an increase in peri-vascular dendritic cells of both the mesenchymal and Plasmacytoid types. These histologic findings on SS skin biopsy are so common that the pathologist may often only mentions them “in passing,” while they emphasize that no leukocytoclastic vasculitic changes were present. But these “perivascular” lymphocytic (and dendritic) cell infiltrates may be the crucial factor in xerosis of SS.
Treatment of SS is generally symptomatic, with most patients requiring treatment only for dryness. Adequate explanation is essential; many subjects, for example, may not realize that their central heating or air conditioning creates a drying environment or that a windy day is likely to make their eyes dryer. Simple measures such as humidifiers, sips of water, chewing gums, and simple replacement tears will be adequate in the majority of subjects. The rest should be told of the wide range of artificial fluids available and encouraged to try several different formulations.
Treatment of other manifestations of SS has been influenced by our treatment of other connective tissue diseases. The most serious (and fortunately rare) complications such as vasculitis and neurologic disease probably require immunosuppression with drugs such as cyclophosphamide, as in systemic lupus erythematosus.
Because many lupus symptoms mimic other illnesses, are sometimes vague and may come and go, lupus can be difficult to diagnose. Diagnosis is usually made by a careful review of a person’s entire medical history coupled with an analysis of the results obtained in routine laboratory tests and some specialized tests related to immune status. Currently, there is no single laboratory test that can determine whether a person has lupus or not. To assist the physician in the diagnosis of lupus, the American Rheumatism Association issued a list of 11 symptoms or signs that help distinguish lupus from other diseases. A person should have four or more of these symptoms to suspect lupus. The symptoms do not all have to occur at the same time
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander, E.L., T.T. Provost (1983) Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J. Invest. Dermatol. 80:386–391
Alexander, E.L., K. Malinow, J.E. Lejewski, M.S. Jerdan, T.T. Provost, and G.E. Alexander. (1986) Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis. Annals of Internal Medicine 104:323–330
Alexander, E., T.T. Provost (1987) Sjögren’s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch. Dermatol. 123:801–810
Allison, P. J., D. Locker, J. S. Feine (1999) The relationship between dental status and health-related quality of life in upper aerodigestive tract cancer patients. Oral Oncol 35(2):138–143
Andonopoulos, A. P., J. Christodoulou, C. Ballas, A. Bounas, D. Alexopoulos (1998) Autonomic cardiovascular neuropathy in Sjogren’s syndrome. A controlled study. J Rheumatol 25(12):2385–2388
Aragona, P., A. Stilo, F. Ferreri, M. Mobrici (2005) Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren’s syndrome patients. Eye 19(5):535–539
Arbuckle, M. R., M. T. McClain, M. V. Rubertone, R. H. Scofield, G. J. Dennis, J. A. James, J. B. Harley (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526–1533
Asherson, R.A., H.M. Fei, H.L. Staub, M.A. Khamashta, G.R.V. Hughes, R.I. Fox (1992) Antiphospholipid antibodies and HLA associations in primary Sjögren’s syndrome. Ann Rheum Dis 51:495–498
Banting, D. W., A. Papas, D. C. Clark, H. M. Proskin, M. Schultz, R. Perry (2000) The effectiveness of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry mouth. Gerodontology 17(2):67–76
Barendregt, P. J., M. J. van Den Bent, V. J. van Raaij-Van Den Aarssen, A. H. van Den Meiracker, C. J. Vecht, G. L. van Der Heijde, H. M. Markusse (2001) Involvement of the peripheral nervous system in primary Sjogren’s syndrome. Ann Rheum Dis 60(9):876–881
Battista, G., M. Zompatori, V. Poletti, R. Canini (2003) Thoracic manifestations of the less common collagen diseases. A pictorial essay. Radiol Med (Torino) 106(5–6):445–451; quiz 52–3
Belafsky, P. C., G. N. Postma (2003) The laryngeal and esophageal manifestations of Sjogren’s syndrome. Curr Rheumatol Rep 5(4):297–303
Belin, C., C. Moroni, N. Caillat-Vigneron, M. Debray, M. Baudin, J. L. Dumas, J. L. Moretti, P. Delaporte, L. Guillevin (1999) Central nervous system involvement in Sjogren’s syndrome: evidence from neuropsychological testing and HMPAO-SPECT [In Process Citation]. Ann Med Interne (Paris) 150(8):598–604
Ben-Chetrit, E., R.I. Fox, E.M. Tan (1990) Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren’s syndrome. Arthritis & Rheum. 33:349–355
Berdoulay, A., R. V. English, B. Nadelstein (2005) Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Vet Ophthalmol 8(4):225–232
Bergdahl, J., M. Bergdahl (2001) Environmental illness: evaluation of salivary flow, symptoms, diseases, medications, and psychological factors. Acta Odontol Scand 59(2): 104–110
Bernacchi, E., L. Amato, A. Parodi, F. Cottoni, P. Rubegni, O. De Pita, M. Papini, A. Rebora, S. Bombardieri, P. Fabbri (2004) Sjogren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol 22(1):55–62
Bernstein, H.N (1991) Ocular safety of hydroxychloroquine. Annals Ophthalmol 23:292–296
Beroukas, D., R. Goodfellow, J. Hiscock, R. Jonsson, T. P. Gordon, S. A. Waterman (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren’s syndrome. Lab Invest 82(2):203–210
Beroukas, D., J. Hiscock, R. Jonsson, S. A. Waterman, T. P. Gordon (2001) Subcellular distribution of aquaporin 5 in salivary glands in primary Sjogren’s syndrome. Lancet 358(9296):1875–1876
Bloch, K.J., W.W. Buchanan, M.J. Wohl, J.J. Bunim (1956) Sjögren’s syndrome: A clinical, pathological and serological study of 62 cases. Medicine (Baltimore) 44:187–231
Bolstad, A. I., H. G. Eiken, B. Rosenlund, M. E. Alarcon-Riquelme, R. Jonsson (2003) Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjogren’s syndrome. Arthritis Rheum 48(1):174–185
Bonafede, R. P., D. C. Downey, R. M. Bennett (1995) An association of fibromyalgia with primary Sjogren’s syndrome: a prospective study of 72 patients. J Rheumatol 22(1):133–136
Bone, R C, R I Fox, F V Howell, R Fantozzi (1985) Sjögren’s syndrome: New immunologic assessments for a persistent clinical problem. Laryngoscope 95:295–299
Borda, E., C. P. Leiros, S. Bacman, A. Berra, L. Sterin-Borda (1999) Sjogren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation. Int J Cardiol 70(1):23–32
Bowman, S. J (2002) Collaborative research into outcome measures in Sjogren’s syndrome. Update on disease assessment. Scand J Rheumatol Suppl (116):23–27
Bowman, S. J., G. H. Ibrahim, G. Holmes, J. Hamburger, J. R. Ainsworth (2004) Estimating the prevalence among Caucasian women of primary Sjogren’s syndrome in two general practices in Birmingham, UK. Scandinavian J Rheumatol 33(1):39–43
Castillo, J. L. and P. Milgrom (2004) Fluoride release from varnishes in two in vitro protocols. J Am Dent Assoc 135(12):1696–1699
Castillo, J. L., P. Milgrom, E. Kharasch, K. Izutsu, M. Fey (2001) Evaluation of fluoride release from commercially available fluoride varnishes. J Am Dent Assoc 132(10): 1389–1392; 459–60
Chan, E K L, K F Sullivan, R I Fox, E M Tan (1989) Sjögren’s syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes. J Autoimmun 2:321–327
Chatterjee, S (2004) Severe interstitial pneumonitis associated with infliximab therapy. Scand J Rheumatol 33(4):276–277
Christensen, L. B., P. E. Petersen, J. J. Thorn, M. Schiodt (2001) Dental caries and dental health behavior of patients with primary Sjogren syndrome. Acta Odontol Scand 59(3): 116–120
Cimaz, R., A. Casadei, C. Rose, J. Bartunkova, A. Sediva, F. Falcini, P. Picco, M. Taglietti, F. Zulian, R. Ten Cate, F. R. Sztajnbok, P. V. Voulgari, A. A. Drosos (2003) Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 162(10):661–665
Cohen, Y., A. Polliack, and A. Nagler (2003) Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and/or High Dose Chemotherapy with Hematopoietic Stem Cell Support. Curr Pharm Des 9(3):279–288
Collin, P., A. L. Karvonen, M. Korpela, P. Laippala, and H. Helin (1997) Gastritis classified in accordance with the Sydney system in patients with primary Sjogren’s syndrome. Scand J Gastroenterol 32(2):108–111
Collin, P., T. Reunala, M. Rasmussen, S. Kyronpalo, E. Pehkonen, P. Laippala, and M. Maki (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133
Constantopoulos, S. H., E. V. Tsianos, H. M. Moutsopoulos (1992) Pulmonary and gastrointestinal manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):617–635
D’Arbonneau, F., S. Ansart, R. Le Berre, M. Dueymes, P. Youinou, and Y. L. Pennec (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthritis Rheum 49(6):804–809
Dabadghao, S., A. Aggarwal, P. Arora, R. Pandey, R. Misra (1995) Glomerulonephritis leading to end stage renal disease in a patient with primary Sjogren syndrome. Clin Exp Rheumatol 13(4):509–511
Dalavanga, Y.A., B. Detrick, J.J. Hooks, A.A. Drosos, H.M. Moutsopoulos (1990) Effect of cyclosporin A (CyA) on the immunopathological lesion of the minor salivary glands from patients with Sjögren’s syndrome. Annals of the Rheu. Diseases 46:89–92
Daniels, T.E.(1984) Labial salivary gland biopsy in Sjögren’s syndrome. Arthritis Rheum. 27:147–156
Daniels, T, Fox, PC (1992) Salivary and Oral Components of Sjogren’s Syndrome. Rheum Clinics NA 18:571–583
Daniels, T. E., P. C. Fox (1992) Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):571–589
Daniels, T. E (2000) Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl 61:6–10
Daniels, T. E., A. J. Wu (2000) Xerostomia — clinical evaluation and treatment in general practice. J Calif Dent Assoc 28(12):933–941
de Seze, J., D. Devos, G. Castelnovo, P. Labauge, S. Dubucquoi, T. Stojkovic, D. Ferriby, P. Vermersch (2001) The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis. Neurology 57(8):1359–1363
Deheinzelin, D., V. L. Capelozzi, R. A. Kairalla, J. V. Barbas Filho, P. H. Saldiva, C. R. de Carvalho (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinical-pathological evaluation and response to treatment [see comments]. Am J Respir Crit Care Med 154(3 Pt 1):794–799
Delalande, S., J. de Seze, A. L. Fauchais, E. Hachulla, T. Stojkovic, D. Ferriby, S. Dubucquoi, J. P. Pruvo, P. Vermersch, P. Y. Hatron (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291
Fei, H.M., H.-I. Kang, S. Scharf, H. Erlich, C. Peebles, R.I. Fox (1991) Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren’s syndrome and autoantibody SS-B production. J. Clin. Lab. Analysis 5:382–391
Feist, E., U. Kuckelkorn, T. Dorner, H. Donitz, S. Scheffler, F. Hiepe, P. M. Kloetzel, G. R Burmester (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42(4):697–702
Fisher, A. 1999. Muscarinic Receptor Agonists in Alzheimer’s Disease. CNS Drugs 12:197–214
Fisher, A., E. Heldman, D. Gurwitz, R. Haring, Y. Karton, H. Meshulam, Z. Pittel, D. Marciano, R. Brandeis, E. Sadot, Y. Barg, R. Pinkas-Kramarski, Z. Vogel, I. Ginzburg, T. A. Treves, R. Verchovsky, S. Klimowsky, A. D. Korczyn (1996) M1 agonists for the treatment of Alzheimer’s disease. Novel properties and clinical update. Ann N YAcad Sci 777(2):189–196
Foster, E. N., K. K. Nguyen, R. A. Sheikh, T. P. Prindiville (2005) Crohn’s disease associated with Sweet’s syndrome and Sjogren’s syndrome treated with Infliximab. Clin Dev Immunol 12(2):145–149
Fox, R I, D A Carson, P Chen, S Fong (1986) Characterization of a cross reactive idiotype in Sjögren’s syndrome. Scandinavian journal of rheumatology 561:83–88
Fox, R I, P P Chen, D A Carson, S Fong (1986) Expression of a cross reactive idiotype on rheumatoid factor in patients with Sjögren’s syndrome. J Immunol 136:477–483
Fox, R I, C Robinson, J Curd, P Michelson, R Bone, F V Howell (1986) First international symposium on Sjögren’s syndrome: Suggested criteria for classification. Scandinavian journal of rheumatology 562:28–30
Fox, R. I., F. V. Howell (1986) Oral problems in patients with Sjögren’s syndrome. Scandinavian journal of rheumatology S61:194–200
Fox, R I, E Chan, L Benton, S Fong, M Friedlaender, F V Howell (1988) Treatment of primary Sjögren’s syndrome with hydroxychloroquine. Amer J Med 85:62–67
Fox, R. I., R. Dixon, V. Guarrasi, S. Krubel (1996) Treatment of primary Sjogren’s syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5Suppl 1:S31–S36
Fox, R (1997) Sjogren’s syndrome: Progress and controversies. Med Clin NA 17:441–534
Fox, R. I., J. Tornwall, P. Michelson (1999) Current issues in the diagnosis and treatment of Sjogren’s syndrome. Curr Opin Rheumatol 11(5):364–371
Fox, R. I (2000) Sjogren’s syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs 9(9):2007–2016
Fox, R. I., Y. Konttinen, A. Fisher (2001) Use of muscarinic agonists in the treatment of Sjogren’s syndrome. Clin Immunol 101(3):249–263
Fox, R. I., M. Stern (2002) Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl (116):3–13
Franceschini, F., P. Calzavara-Pinton, M. Quinzanini, I. Cavazzana, L. Bettoni, C. Zane, F. Facchetti, P. Airo, D. P. McCauliffe, R. Cattaneo (1999) Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8(3):215
Fulop, M., M. Mackay (2004) Renal tubular acidosis, Sjogren syndrome, and bone disease. Arch Intern Med 164(8):905–909
Gaither, K.K., O.W. Fox, H. Yamagata, M.J. Mamula, M. Reichlin, J.B. Harley (1987) Implications of anti-Ro/Sjögren’s syndrome A antigen autoantibody in normal sera for autoimmunity. J. Clin. Invest. 79:841–846
Gamron, S., G. Barberis, C. M. Onetti, I. Strusberg, E. Hliba, G. Martellotto, H. G. Jara, A. M. Sesin (2000) Mesangial nephropathy in Sjogren’s syndrome. Scandinavian journal of rheumatology 29(1):65–67
Grant, I. A., G. G. Hunder, H. A. Homburger, P. J. Dyck (1997) Peripheral neuropathy associated with sicca complex. Neurology 48(4):855–862
Gross, W. L (1999) New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 11(1):41–46
Gyongyosi, M., G. Pokorny, Z. Jambrik, L. Kovacs, A. Kovacs, E. Makula, M. Csanady (1996) Cardiac manifestations in primary Sjogren’s syndrome. Ann Rheum Dis 55(7):450–454
Gyulai, R., M. Kiss, M. Mehravaran, L. Kovacs, G. Pokorny, S. Husz, A. Dobozy (2002) Atypical autoimmune blistering dermatosis associated with Sjogren’s syndrome. Acta Derm Venereol 82(6):462–464
Haimowitz, J. E., D. P. McCauliffe, J. Seykora, V. P. Werth (2000) Annular erythema of Sjogren’s syndrome in a white woman. J Am Acad Dermatol 42(6): 1069–1072
Hamano, T (2005) Lacrimal duct occlusion for the treatment of dry eye. Semin Ophthalmol 20(2):71–74
Hamilton, R.G., J.B. Harley, W. B. Bias, al et (1988) Two Ro (SS-A) autoantibody responses in systemic lupus erythematous. Arthritis Rheum. 31:446–505
Harley, J.B., E.L. Alexander, W.B. Bias, O.F. Fox, T.T. Provost, M. Richlin, H. Yanagata, F.C. Arnett (1986) Anti-Ro (SS-A) and Anti-La (SS-B) in patients with Sjögren’s syndrome. Arthritis Rheum 29:196–206
Hay, K. D, R. P. Morton (2003) The efficacy of casein phosphoprotein-calcium phosphate complex (DC-CP) [Dentacal] as a mouth moistener in patients with severe xerostomia. N Z Dent J 99(2):46–48
Hay, K. D., W. M. Thomson (2002) A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(3):271–275
Heinlen, L. D., M. T. McClain, X. Kim, D. R. Quintero, J. A James, J. B. Harley, R. H. Scofield (2003) Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus 12(4):335–337
Illei, G. G., E. Tackey, L. Lapteva, P. E. Lipsky (2004) Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 50(7):2048–2065
Invernizzi, P., P. M. Battezzati, A. Crosignani, P. Zermiani, M. Bignotto, N. Del Papa, M. Zuin, M. Podda (1998) Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol 114(3):448–454
Isidor, F., K. Brondum, H. J. Hansen, J. Jensen, S. Sindet-Pedersen (1999) Outcome of treatment with implant-retained dental prostheses in patients with Sjogren syndrome. Int J Oral Maxillofac Implants 14(5):736–743
Ito, Y., N. Kanda, H. Mitsui, T. Watanabe, S. Kobayashi, S. Murayama, K. Tamaki (1999) Cutaneous manifestations of Sjogren’s syndrome associated with myasthenia gravis [letter]. Br J Dermatol 141(2):362–363
Johnson, E. O., P. G. Vlachoyiannopoulos, F. N. Skopouli, A. G. Tzioufas, H. M. Moutsopoulos (1998) Hypofunction of the stress axis in Sjogren’s syndrome. J Rheumatol 25(8):1508–1514
Jonsson, R., T. P. Gordon, Y. T. Konttinen (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren’s syndrome. Curr Rheumatol Rep 5(4):311–316
Josephs, S.F., A. Buchbinder, H.Z. Streicher, D.V. Ablashi, S.Z. Salahuddin, H.G. Guo, R.F. Krueger, R.I. Fox, R.C. Gallo (1988) Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B-cell lymphoma tissues of three patients. Leukemia 2:132–135
Jubert, C., A. Cosnes, T. Clerici, P. Gaulard, P. Andre, J. Revuz, M. Bagot (1993) Sjogren’s syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum 36(1): 133–134
Kamel, O. W., M. van de Rijn, L. M. Weiss, G. J. Del Zoppo, P. K. Hench, B. A. Robbins, P. G. Montgomery, R. A. Warnke, R. F. Dorfman (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328(18):1317–1321
Kassan, S.S., T.L. Thomas, H.M. Moutsopoulos, R. Hoover, R.P. Kimberly, D.R. Budman, J. Costa, J.L. Decker, T.M. Chused (1978) Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89:888–892
Katayama, I., T. Yamamoto, K. Otoyama, T. Matsunaga, K. Nishioka (1994) Clinical and immunological analysis of annular erythema associated with Sjogren syndrome. Dermatology 189Suppl 1:14–17
Katayama, Y., K. Kohriyama (2001) Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol 28(2):288–291
Katelaris, C. H. (2005) Pilocarpine for Dry Mouth and Dry Eye in Sjogren’s Syndrome. Curr Allergy Asthma Rep 5(4):321
Kaufman, K. M., M. Y. Kirby, M. T. McClain, J. B. Harley, J. A. James (2001) Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B’. Biochem Biophys Res Commun 285(5): 1206–1212
Kim, B. M., S. S. Osmanovic, D. P. Edward (2005) Pyogenic granulomas after silicone punctal plugs: a clinical and histopathologic study. Am J Ophthalmol 139(4):678–684
Kim, E. A., K. S. Lee, T. Johkoh, T. S. Kim, G. Y. Suh, O. J. Kwon, J. Han (2002) Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 22 Spec No:S151–S165
Konishi, M., Y. Ohosone, M. Matsumura, Y. Oyamada, K. Yamaguchi, Y. Kawahara, T. Mimori, Y. Ikeda (1997) Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms. Intern Med 36(1):62–67
Konttinen, Y. T., L. Kasna-Ronkainen (2002) Sjogren’s syndrome: viewpoint on pathogenesis. One of the reasons I was never asked to write a textbook chapter on it. Scand J Rheumatol Suppl (116):15–22
Konttinen, Y.T., M. Hukkanen, P. Kemppinen, M. Segerberg, al. et. (1992) Peptide-containing nerves in labial salivary glands in Sjögren’s syndrome. Arthritis Rheum 35:815–820
Kruize, A., R. Hene, C. Kallenberg, O. van Bijsterveld, A. van der Heide, L. Kater, J. Bijlsma (1993) Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360–364
Kyle, R., G. Gleich, E. Baynd, and et a. (1971) Benign hyperglobuliemic purpura of Waldenstrom. Medicine (Baltimore) 50:113–123
Lass, P., J. Krajka-Lauer, M. Homziuk, B. Iwaszkiewicz-Bilikiewicz, M. Koseda, M. Hebanowski, P. Lyczak (2000) Cerebral blood flow in Sjogren’s syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21(1):31–35
Leppilahti, M., T. L. Tammela, H. Huhtala, P. Kiilholma, K. Leppilahti, A. Auvinen (2003) Interstitial cystitis-like urinary symptoms among patients with Sjogren’s syndrome: a population-based study in Finland. Am J Med 115(1):62–65
Li, J. M., A. C. Horsfall, R. N. Maini (1995) Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin — a role in the pathogenesis of congenital heart block? Clin Exp Immunol 99(3):316–324
Lightfoot, R. (1997) Cost Effective use of Laboratory Tests in Rheumatology. Bul Rheum Dis 46:1–3
Lindvall, B., A. Bengtsson, J. Ernerudh, P. Eriksson (2002) Subclinical myositis is common in primary Sjogren’s syndrome and is not related to muscle pain. J Rheumatol 29(4):717–725
Lwin, C. T., M. Bishay, R. G. Platts, D. A. Booth, S. J. Bowman (2003) The assessment of fatigue in primary Sjogren’s syndrome. Scandinavian journal of rheumatology 32(1):33–37
Manoussakis, M. N., C. Georgopoulou, E. Zintzaras, M. Spyropoulou, A. Stavropoulou, F. N. Skopouli, H. M. Moutsopoulos (2004) Sjogren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren’s syndrome. Arthritis Rheum 50(3):882–891
Marriette, X. (2003) Lack of benefit of Infliximab in Sjogren’s Syndrome. Arth Rhem abstract S19
McClain, M. T., L. D. Heinlen, G. J. Dennis, J. Roebuck, J. B. Harley, J. A. James (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11(1):85–89
Merkel, P. A., Y. Chang, S. S. Pierangeli, K. Convery, E. N. Harris, R. P. Polisson (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583
Merkel, P. A., R. P. Polisson, Y. Chang, S. J. Skates, J. L. Niles (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873
Mikulicz, J.H. (1892) Uber eine eigenartige symmetrische Erkrankung der Tranen-und Mundspeicheldrusen. In Beitr. Chir. Fortschr., edited by G. T. Billroth. Stuttgart
Millard, L. G., N. R. Rowell (1978) Chilblain lupus erythematosus (Hutchinson) A CLINICAL AND LABORATORY STUDY OF 17 PATIENTS. British Journal of Dermatology 98(5):497–506
Miyagawa, S., T. Iida, T. Fukumoto, T. Matsunaga, A. Yoshioka, T. Shirai (1995) Anti-Ro/SSA-associated annular erythema in childhood. Br J Dermatol 133(5):779–782
Morgan, W., B Castleman (1953) A clinicopathologic study of Mikulicz’a disease. Am J Pathol 29:471–503
Mori, K., M. Iijima, H. Koike, N. Hattori, F. Tanaka, H. Watanabe, M. Katsuno, A. Fujita, I. Aiba, A. Ogata, T. Saito, K. Asakura, M. Yoshida, M. Hirayama, G. Sobue (2005) The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy. Brain 128(Pt 11):2518–2534
Musadiq, M., S. Mukherji, S. Sandramouli (2005) Pyogenic granuloma following silicone punctal plugs: report of two cases. Orbit 24(2):149–151
Nakamura, H., A. Kawakami, M. Tominaga, A. Hida, S. Yamasaki, K. Migita, Y. Kawabe, T. Nakamura, K. Eguchi (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients [In Process Citation]. J Lab Clin Med 135(2): 139–144
Navarro, M., R. Cervera, J. Font, J. C. Reverter, J. Monteagudo, G. Escolar, A. Lopez-Soto, A. Ordinas, M. Ingelmo (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6(6):521–526
Nishimagi, E., Y. Kawaguchi, C. Terai, H. Kajiyama, M. Hara, N. Kamatani (2001) Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome. Intern Med 40(10):1059–1063
Nishimori, I., K. Okazaki, Y. Yamamoto, M. Morita, S. Tamura, Y. Yamamoto (1993) Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjögren’s syndrome. J Clin Immunol 13(4):265–271
Nishimura, M., S. Miyajima, N. Okada (2000) Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjogren’s Syndrome [In Process Citation]. J Dermatol 27(7):450–452
O’Donnell, B., A. K. Black (1995) Urticarial vasculitis. Int Angiol 14(2):166–174
Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, S. Sugai (2002) Involvement of the interferon-gammainduced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren’s syndrome. Arthritis Rheum 46(10):2730–2741
Pablos, J. L., V. Cogolludo, F. Pinedo, P. E. Carreira (1993) Subcutaneous nodular amyloidosis in Sjögren’s syndrome. Scandinavian journal of rheumatology 22:250–251
Papas, A. S., A. Joshi, S. L. MacDonald, L. Maravelis-Splagounias, P. Pretara-Spanedda, F. A. Curro (1993) Caries prevalence in xerostomic individuals. J Can Dent Assoc 59(2):171–174, 7–9
Papas, A. S., A. Joshi, A. J. Belanger, R. L. Kent, Jr., C. A. Palmer, P. F. DePaola (1995) Dietary models for root caries. Am J Clin Nutr 61(2):417S–422S
Papas, A. S., A. Joshi, C. A. Palmer, J. L. Giunta, J. T. Dwyer (1995) Relationship of diet to root caries. Am J Clin Nutr 61(2):423S–429S
Papas, A. S., M. M. Fernandez, R. A. Castano, S. C. Gallagher, M. Trivedi, R. C. Shrotriya (1998) Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogrens syndrome. Adv Exp Med Biol 438:973–978
Pease, C. T., W. Shattles, N. K. Barrett, R. N. Maini (1993) The arthropathy of Sjogren’s syndrome. Br J Rheumatol 32(7):609–613
Pender, M. P. (1999) Recent progress in the diagnosis and treatment of multiple sclerosis. J Clin Neurosci 6(5):367–372
Perez, B., A. Kraus, G. Lopez, M. Cifuentes, D. Alarcon-Segovia (1995) Autoimmune thyroid disease in primary Sjogren’s syndrome. Am J Med 99(5):480–484
Pers, J. O., F. d’Arbonneau, V. Devauchelle-Pensec, A. Saraux, Y. L. Pennec, P. Youinou (2005) Is periodontal disease mediated by salivary baff in sjogren’s syndrome? Arthritis Rheum 52(8):2411–2414
Pers, J. O., C. Daridon, V. Devauchelle, S. Jousse, A. Saraux, C. Jamin, P. Youinou (2005) BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases. Ann N Y Acad Sci 1050:34–39
Petrone, D., J. J. Condemi, R. Fife, O. Gluck, S. Cohen, P. Dalgin (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46(3):748–754
Pflugfelder, S. C. (1996) Differential diagnosis of dry eye conditions. Adv Dent Res 10(1):9–12
Pflugfelder, S. C. (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137(2):337–342
Pillemer, S. R., E. L. Matteson, L. T. Jacobsson, P. B. Martens, L. J. Melton, 3rd, W. M. O’Fallon, P. C. Fox (2001) Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593–599
Pirildar, T., C. Tikiz, S. Ozkaya, S. Tarhan, O. Utuk, H. Tikiz, U. K. Tezcan (2005) Endothelial dysfunction in patients with primary Sjogren’s syndrome. Rheumatology international 25(7):536–539
Press, J., Y. Uziel, R. M. Laxer, L. Luy, R. M. Hamilton, E. D. Silverman (1996) Long-term outcome of mothers of children with complete congenital heart block. Am J Med 100(3):328–332
Price, E. J., S. P. Rigby, U. Clancy, P. J. Venables (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren’s syndrome. J Rheumatol 25(5):896–899
Provost, T. T., R. Watson (1992) Cutaneous manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):609–616
Provost, T. T., R. Watson, O. Brien E. Simmons (1997) Anti-Ro(SS-A) antibody positive Sjogren’s/ lupus erythematosus overlap syndrome. Lupus 6(2): 105–111
Provost, T. T., R. Watson, E. Simmons-O’Brien (1997) Anti-Ro(SS-A) antibody positive Sjogren’s/ lupus erythematosus overlap syndrome. Lupus 6(2): 105–111
Quismorio, F. P., Jr. (1996) Pulmonary involvement in primary Sjogren’s syndrome. Curr Opin Pulm Med 2(5):424–428
Rader, M.D., C. O’Brien, Y. Liu, J.B. Harley, M. Reichlin (1989) Heterogeneity of the Ro/SSA antigen. J. Clin. Invest. 83:1293–1298
Raderer, M., C. Osterreicher, K. Machold, M. Formanek, W. Fiebiger, M. Penz, B. Dragosics, A. Chott (2001) Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 12(7):937–939
Radfar, L., D. E. Kleiner, P. C. Fox, S. R. Pillemer (2002) Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 47(5):520–524
Ramos-Casals, M., J. M. Anaya, M. Garcia-Carrasco, J. Rosas, A. Bove, G. Claver, L. A. Diaz, C. Herrero, J. Font (2004) Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 83(2):96–106
Ramos-Casals, M., R. Cervera, J. Yague, M. Garcia-Carrasco, O. Trejo, S. Jimenez, R. M. Morla, J. Font, M. Ingelmo (1998) Cryoglobulinemia in primary Sjogren’s syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 28(3):200–205
Robinson, C. P., H. Yamamoto, A. B. Peck, M. G. Humphreys-Beher (1996) Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 79(1):50–59
Robinson, C., S. Yamciuka, C. Alford, C. Cooper, E. Pichardo, N. Shah, M. Peck, M. Humphrey-Beher (1997) Elevated levels of cysteine protease activity in saliva and salivary glands of NOD mouse model for Sjogren’s syndrome. Proc Nat Acad Sci 94:5767–5771
Roguedas, A. M., L. Misery, B. Sassolas, G. Le Masson, Y. L. Pennec, P. Youinou (2004) Cutaneous manifestations of primary Sjogren’s syndrome are underestimated. Clin Exp Rheumatol 22(5):632–636
Rosler, D. H., M. D. Conway, J. M. Anaya, J. F. Molina, R. F. Carr, A. E. Gharavi, W. A. Wilson (1995) Ischemic optic neuropathy and high-level anticardiolipin antibodies in primary Sjogren’s syndrome. Lupus 4(2):155–157
Royer, B., D. Cazals-Hatem, J. Sibilia, F. Agbalika, J. M. Cayuela, T. Soussi, F. Maloisel, J. P. Clauvel, J. C. Brouet, X. Mariette (1997) Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90(2):766–775
Rustin, M. H. A., J. A. Newton, N. P. Smith, P. M. Dowd (1989) The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. British Journal of Dermatology 120(2):267–275
Ruzicka, T., J. Faes, T. Bergner, R. U. Peter, O. Braun-Falco (1991) Annular erythema associated with Sjogren’s syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol 25(3):557–560
Sais, G., C. Admella, M. J. Fantova, J. C. Montero (1998) Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjogren’s syndrome. Br J Dermatol 139(6): 1073–1076
Salaffi, F., G. Argalia, M. Carotti, F. B. Giannini, C. Palombi (2000) Salivary gland ultrasonography in the evaluation of primary Sjogren’s syndrome. Comparison with minor salivary gland biopsy. J Rheumatol 27(5):1229–1236
Sall, K, OD Stevenson, TK Mundorf, BL Reis (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107(4):631
Sankar, V., M. T. Brennan, M. R. Kok, R. A. Leakan, J. A. Smith, J. Manny, B. J. Baum, S. R. Pillemer (2004) Etanercept in Sjogren’s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 50(7):2240–2245
Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, A. N. Theofilopoulos (2003) Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197(6):777–788
Sawalha, A. H., R. Potts, W. R. Schmid, R. H. Scofield, J. B. Harley (2003) The genetics of primary Sjogren’s syndrome. Curr Rheumatol Rep 5(4):324–332
Schiodt, M., L. B. Christensen, P. E. Petersen, J. J. Thorn (2001) Periodontal disease in primary Sjogren’s syndrome. Oral Dis 7(2): 106–108
Scofield, R. H., B. T. Kurien, F. Zhang, P. Mehta, K. Kaufman, T. Gross, M. Bachmann, T. Gordon, J. B. Harley (1999) Protein-protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides [In Process Citation]. Mol Immunol 36(15–16):1093–1106
Sestak, A.L., J.B. Harley, S. Yoshida, M. Reichlin (1987) Lupus/Sjögren’s autoantibody specificities in sera with paraproteins. J. Clin. Invest. 80:138–144
Sheikh, S. H., T. A. Shaw-Stiffel (1995) The gastrointestinal manifestations of Sjogren’s syndrome. Am J Gastroenterol 90(1):9–14
Shibata, S., Y. Ubara, N. Sawa, T. Tagami, J. Hosino, M. Yokota, H. Katori, F. Takemoto, S. Hara, K. Takaichi, A. Fujii, H. Murata, T. Nishi (2004) Severe interstitial cystitis associated with Sjogren’s syndrome. Intern Med 43(3):248–252
Siamopoulos, K. C., M. Elisaf, H. M. Moutsopoulos (1994) Hypokalaemic paralysis as the presenting manifestation of primary Sjogren’s syndrome. Nephrol Dial Transplant 9(8): 1176–1178
Simmons-O’Brien, E., S. Chen, R. Watson, C. Antoni, M. Petri, M. Hochberg, M. B. Stevens, T. T. Provost (1995) One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 74(3): 109–130
Skopouli, F. N., P. Jagiello, N. Tsifetaki, H. M. Moutsopoulos (1996) Methotrexate in primary Sjogren’s syndrome. Clin Exp Rheumatol 14(5):555–558
Soto-Rojas, A. E., A. Kraus (2002) The oral side of sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res 33(2):95–106
Spezialetti, R., H. G. Bluestein, J. B. Peter, E. L. Alexander (1993) Neuropsychiatric disease in Sjogren’s syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 95(2):153–160
Steinfeld, S. D., P. Demols, I. Salmon, R. Kiss, T. Appelboom (2001) Infliximab in patients with primary Sjogren’s syndrome: a pilot study. Arthritis Rheum 44(10):2371–2375
Stern, M. E., R. W. Beuerman, R. I. Fox, J. Gao, A. K. Mircheff, S. C. Pflugfelder (1998) A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 438:643–651
Strong, B., W. Farley, M. E. Stern, S. C. Pflugfelder (2005) Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 24(1):80–85
Suzuki, K., M. Matsumoto, M. Nakashima, K. Takada, T. Nakanishi, M. Okada, F. Ohsuzu (2005) Effect of cevimeline on salivary components in patients with Sjogren syndrome. Pharmacology 74(2): 100–105
Swords, R., D. Power, M. Fay, R. O’Donnell, P. T. Murphy (2004) Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 77(1): 103–104
Takeda, K., T. Kaisho, S. Akira (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Tan, E. M., T. E. Feltkamp, J. S. Smolen, B. Butcher, R. Dawkins, M. J. Fritzler, T. Gordon, J. A. Hardin, J. R. Kalden, R. G. Lahita, R. N. Maini, J. S. McDougal, N. F. Rothfield, R. J. Smeenk, Y. Takasaki, A. Wiik, M. R. Wilson, J. A. Koziol (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40(9):1601–1611
Tapinos, N. I., M. Polihronis, A. G. Tzioufas, H. M. Moutsopoulos (1999) Sjogren’s syndrome. Autoimmune epithelitis. Adv Exp Med Biol 455:127–134
Tatlipinar, S., E. K. Akpek (2005) Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 89(10):1363–1367
Tektonidou, M. G., M. Anapliotou, P. Vlachoyiannopoulos, H. M. Moutsopoulos (2004) Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 63(9):1159–1161
Tektonidou, M., E. Kaskani, F. N. Skopouli, H. M. Moutsopoulos (1999) Microvascular abnormalities in Sjogren’s syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 38(9):826–830
Tensing, E. K., S. A. Solovieva, T. Tervahartiala, D. C. Nordstrom, M. Laine, S. Niissalo, Y. T. Konttinen (2001) Fatigue and health profile in sicca syndrome of Sjogren’s and non-Sjogren’s syndrome origin. Clin Exp Rheumatol 19(3):313–316
Tishler, M., I. Alosachie, N. Barka, H. C. Lin, M. E. Gershwin, J. B. Peter, Y. Shoenfeld (1995) Primary Sjogren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 13(4):497–500
Tishler, M., Y. Barak, D. Paran, M. Yaron (1997) Sleep disturbances, fibromyalgia and primary Sjogren’s syndrome. Clin Exp Rheumatol 15(1):71–74
Tonami, H., K. Higashi, M. Matoba, H. Yokota, I. Yamamoto, S. Sugai (2001) A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjogren syndrome. J Comput Assist Tomogr 25(2):262–268
Urban, P. P., A. Keilmann, E. M. Teichmann, H. C. Hopf (2001) Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjogren’s syndrome. J Neurol Sci 186(1–2):59–63
Utset, T. O., M. Golden, G. Siberry, N. Kiri, R. M. Crum, M. Petri (1994) Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren’s syndrome. J Rheumatol 21(11):2039–2045
van Dam, A. P., E. M. Wekking, J. A. Callewaert, A. J. Schipperijn, H. A. Oomen, J. de Jong, A. J. Swaak, R. J. Smeenk, T. E. Feltkamp (1994) Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatology international 14(2):57–62
Vitali, C. (2003) Classification criteria for Sjogren’s syndrome. Ann Rheum Dis 62(1):94–95; author reply 5
Vitali, C., H. M. Moutsopoulos, S. Bombardieri (1994) The European Community Study Group on diagnostic criteria for Sjogren’s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s syndrome. Ann Rheum Dis 53(10):637–647
Vivino, F. B., I. Gala, G. A. Hermann (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29(5):938–944
Voulgarelis, M., U. G. Dafni, D. A. Isenberg, H. M. Moutsopoulos (1999) Malignant lymphoma in primary Sjogren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren’s Syndrome. Arthritis Rheum 42(8):1765–1772
Wall, G. C., M. L. Magarity, J. W. Jundt (2002) Pharmacotherapy of xerostomia in primary Sjogren’s syndrome. Pharmacotherapy 22(5):621–629
Wallace, D. (1994) Antimalarial agents and lupus. Rheum Dis Clinics NA 20:243–263
Wallace, D. J. 2002. Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 14(3):212–219
Watanabe, T., T. Tsuchida, M. Furue, S. Yoshinoya (1996) Annular erythema, dermatomyositis, and Sjogren’s syndrome. Int J Dermatol 35(4):285–287
Watanabe, T., T. Tsuchida, Y. Ito, N. Kanda, Y. Ueda, K. Tamaki (1997) Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J Am Acad Dermatol 36:214–218
Wu, A. J. (2003) The oral component of Sjogren’s syndrome: pass the scalpel and check the water. Curr Rheumatol Rep 5(4):304–310
Wu, A. J., P. C. Fox (1994) Sjogren’s syndrome. Semin Dermatol 13(2):138–143
Yamamoto, H., K. Ishibashi, Y. Nakagawa, N. Maeda, T. Zeng, C. P. Robinson, G. E. Oxford, N. Chegini, M. G. Humphreys-Beher (1997) Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis. Scand J Immunol 45(1):55–61
Yamamoto, T., I. Katayama, K. Nishioka (1998) Analysis of T cell receptor Vbeta repertoires of annular erythema associated with Sjogren’s syndrome. Eur J Dermatol 8(4):248–251
Yoneyama, K., N. Tochigi, A. Oikawa, H. Shinkai, A. Utani (2005) Primary localized cutaneous nodular amyloidosis in a patient with Sjogren’s syndrome: a review of the literature. J Dermatol 32(2):120–123
Yousem, D. M., M. A. Kraut, A. A. Chalian (2000) Major salivary gland imaging. Radiology 216(1):19–29
Zandbelt, M. M., P. de Wilde, P. van Damme, C. B. Hoyng, L. van de Putte, F. van den Hoogen (2004) Etanercept in the treatment of patients with primary Sjogren’s syndrome: a pilot study. J Rheumatol 31(1):96–101
Zukowski, T. H., R. A. Jorgensen, E. R. Dickson, K. D. Lindor (1998) Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. Am J Gastroenterol 93(6):958–961
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2011 Springer-Verlag/Wien
About this chapter
Cite this chapter
Fox, R.I., Fox, C.M. (2011). Sjögren’s Syndrome. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/978-3-211-99225-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-211-99225-8_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-99224-1
Online ISBN: 978-3-211-99225-8
eBook Packages: MedicineMedicine (R0)